These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16932617)

  • 1. Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?
    Huizinga TW; Landewé RB
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):2-3. PubMed ID: 16932617
    [No Abstract]   [Full Text] [Related]  

  • 2. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.
    Raza K; Saber TP; Kvien TK; Tak PP; Gerlag DM
    Ann Rheum Dis; 2012 Dec; 71(12):1921-3. PubMed ID: 22941769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for altering rheumatoid arthritis outcome.
    Quinn MA; Emery P
    Rheum Dis Clin North Am; 2005 Nov; 31(4):763-72. PubMed ID: 16287596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early therapy -- later retirement].
    Fath R
    MMW Fortschr Med; 2004 Sep; 146(37):6, 8. PubMed ID: 15887692
    [No Abstract]   [Full Text] [Related]  

  • 6. Are biologics more effective than classical disease-modifying antirheumatic drugs?
    Nurmohamed MT; Dijkmans BA
    Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.
    van Roon JA; Jacobs K; Verstappen S; Bijlsma J; Lafeber F
    Ann Rheum Dis; 2008 Jul; 67(7):1054-5. PubMed ID: 18556451
    [No Abstract]   [Full Text] [Related]  

  • 8. Tailor-made therapy in rheumatoid arthritis: fact or fiction?
    Haroon N; Misra R; Aggarwal A
    Isr Med Assoc J; 2008 Feb; 10(2):139-41. PubMed ID: 18432029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the window of opportunity concept in early rheumatoid arthritis.
    Boers M
    Arthritis Rheum; 2003 Jul; 48(7):1771-4. PubMed ID: 12847667
    [No Abstract]   [Full Text] [Related]  

  • 10. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
    Weisman MH
    Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
    [No Abstract]   [Full Text] [Related]  

  • 11. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 12. How aggressive should initial therapy for rheumatoid arthritis be?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2005 Jan; 44(1):133-4; author reply 135-6. PubMed ID: 15611309
    [No Abstract]   [Full Text] [Related]  

  • 13. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
    Kaarela K; Hakala M; Hannonen P; Kautiainen H; Korpela M; Leirisalo-Repo M; Luosujärvi R; Luukkainen R; Möttönen T; Puolakka K
    Rheumatology (Oxford); 2005 Jan; 44(1):134-5; author reply 135-6. PubMed ID: 15611310
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomes.
    Keystone EC
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):594-601. PubMed ID: 17075598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study.
    Kary S; Fritz J; Scherer HU; Burmester GR
    Rheumatology (Oxford); 2004 Jul; 43(7):819-20. PubMed ID: 15187247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Stable remission of early active rheumatoid arthritis treated with etanercept (Enbrel)].
    Kaliterna DM
    Reumatizam; 2008; 55(2):60-1. PubMed ID: 19024277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and aggressive treatment affects the association of HLA-DRB1 genes with progression of joint damage: comment on the article by Lard et al.
    Rau R; Herborn G; Fenner H
    Arthritis Rheum; 2003 Feb; 48(2):579. PubMed ID: 12571873
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologic therapy for early rheumatoid arthritis: the latest evidence.
    Castro-Rueda H; Kavanaugh A
    Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.